Emerging Growth Research Initiates Coverage on Virtuix Holdings Inc. (VTIX) with Buy-Emerging Rating and $9.00 Price Target

The initiation report covers Virtuix's market-leading, patent-protected, AI-driven virtual reality platform and its dual-use growth strategy spanning the consumer and defense markets. Emerging Growth Research believes current share prices reflect an unwarranted overreaction to strategy-unrelated selling pressure, creating a compelling entry point for long-term investors ahead of an expected hockey stick revenue inflection in calendar 2027 and beyond.

Key Highlights from the Initiation Report

• Market-Leading, Patent-Protected Consumer VR Platform Virtuix's Omni One omni-directional treadmill is the premier full-body VR movement system for consumers, enabling users to walk and run 360 degrees inside virtual reality games and fitness applications. With 25 granted patents (and 5 pending), 3,000 units/month production capacity equivalent to $100 million in annual revenue, and a new distribution partnership with Meta's six million Quest headset user base, Virtuix is ready to scale into rapidly growing VR, gaming, and fitness markets.

• Emerging Defense Opportunity Adds Significant Upside Virtuix's Virtual Terrain Walk (VTW) platform enables military personnel to physically walk through geo-specific virtual terrain for immersive mission planning and rehearsal. The Company has secured initial contracts and funding from the U.S. Air Force (SBIR Phase 1), U.S. Marine Corps, and U.S. Navy, with additional sales to West Point, the U.S. Air Force Academy, and Yokota Air Force Base. Defense gross margins are estimated at 60-70%. Management is also actively pursuing defense M&A targeting cash flow positive companies with $10-$50 million in revenue.

• Revenue Growth Expected to Display Hockey Stick Profile in CY 2027+ Emerging Growth Research estimates approximately 20% revenue growth in fiscal 2027, followed by approximately 300% growth in fiscal 2028 as consumer and defense markets accelerate. Trailing nine-month revenue through December 2025 increased 41% year-over-year, with consumer December 2025 sales up 60% versus December 2024. Near-term reported growth is expected to remain muted through calendar H1 2026 due to prior-year order backlog comparisons, before resuming a strong upward trajectory.

• Share Price Decline Reflects Unmerited Selling, Not Business Fundamentals Since its January 2026 IPO at $8.75, VTIX shares have experienced significant selling pressure following a small, predetermined 10b5-1 share sale by the Company's CEO - representing approximately 10% of his holdings - that was established long before the IPO and could not be altered or cancelled. Emerging Growth Research views the resulting share price decline as an overreaction, and notes that shares have begun to recover, rising approximately 25% off May 2026 lows. With $9.5 million in cash on the balance sheet as of March 31, 2026, the Company is funded through calendar year 2026 without requiring additional external financing.

For a copy of the full Initiation Report, please visit: